Richard I. Fisher has stepped down from his roles as Fox Chase Cancer Center president and CEO, Fox Chase Cancer Center director, and senior associate dean for cancer programs at the Lewis Katz School of Medicine at Temple University.
As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.
